Side Effects of Flagyl (Metronidazole)
Metronidazole is associated with gastrointestinal side effects, a disulfiram-like reaction with alcohol, peripheral neuropathy with prolonged therapy, and rare but serious neuropsychiatric effects including seizures and encephalopathy. 1, 2
Common Side Effects
Gastrointestinal Effects
- Nausea occurs in approximately 12% of patients, sometimes accompanied by headache, anorexia, and vomiting 2
- Diarrhea, epigastric distress, abdominal cramping, and constipation are frequently reported 2, 3
- These gastrointestinal effects are generally mild to moderate in severity 3
Oral and Taste Disturbances
- A sharp, unpleasant metallic taste is common and not unusual 2
- Furry tongue, glossitis, and stomatitis may occur, often associated with sudden Candida overgrowth during therapy 2
- Dryness of the mouth has been reported 2
Urine Discoloration
- Darkened urine occurs in approximately 1 in 100,000 patients 2
- Reddish discoloration of urine has been documented and typically resolves within 24 hours of discontinuing metronidazole 4
- This pigmentation is likely a metabolite of metronidazole and has no clinical significance 2
Serious Neurological Side Effects
Peripheral Neuropathy
- Peripheral neuropathy is characterized mainly by numbness or paresthesia of an extremity 2
- Persistent peripheral neuropathy has been reported with prolonged administration 1, 2
- Patients should be specifically warned about this reaction and told to stop the drug immediately if any neurologic symptoms occur 2
Central Nervous System Effects
- Convulsive seizures represent one of the two most serious adverse reactions 2
- Dizziness, vertigo, incoordination, ataxia, confusion, irritability, depression, weakness, and insomnia have been reported 2
- Serious neurotoxicity, optic neuropathy, and encephalopathy occur in rare cases 3
- Neuropsychiatric effects appear to be dose- and serum concentration-related, with symptoms resolving within 24-48 hours after discontinuation 5
- Higher doses increase the likelihood of anxiety symptoms 5
Critical Safety Warning
- Repeated or prolonged courses of metronidazole should be avoided due to the risk of cumulative and potentially irreversible neurotoxicity 5, 6, 7
- This risk is particularly dangerous in patients with impaired drug clearance states 5
Alcohol Interaction (Disulfiram-Like Reaction)
- If patients drink alcoholic beverages while taking metronidazole, they may experience abdominal distress, nausea, vomiting, flushing, or headache 1, 2
- This reaction is similar to disulfiram (Antabuse) and results from accumulation of acetaldehyde in the blood 8
- A modification of the taste of alcoholic beverages has also been reported 2
- One case of sudden death has been documented due to cardiac dysrhythmia from acetaldehyde toxicity in a patient taking metronidazole with ethanol 8
Hematologic Effects
- Reversible neutropenia (leukopenia) can occur 2
- Reversible thrombocytopenia occurs rarely 2
- Metronidazole lacks the predictable irreversible hematologic toxicity seen with chloramphenicol 9
Cardiovascular Effects
- Flattening of the T-wave may be seen on electrocardiographic tracings 2
- Acetaldehyde (from alcohol interaction) is cardiotoxic and arrhythmogenic 8
Hypersensitivity Reactions
- Urticaria, erythematous rash, flushing, nasal congestion, dryness of mouth/vagina/vulva, and fever have been reported 2
Genitourinary Effects
- Dysuria, cystitis, polyuria, incontinence, and a sense of pelvic pressure 2
- Proliferation of Candida in the vagina, dyspareunia, and decrease of libido 2
Other Rare Effects
- Rare cases of pancreatitis, which generally abate on withdrawal of the drug 2
- Proctitis and fleeting joint pains sometimes resembling "serum sickness" 2
Important Clinical Considerations
Monitoring Requirements
- Patients should be specifically warned about neurologic reactions and instructed to stop the drug and report immediately if any neurologic symptoms occur 2
- Assess neurological status at each clinical encounter when using metronidazole 7
Common Pitfall to Avoid
- Do not prescribe repeated or prolonged courses due to cumulative neurotoxicity risk 5, 6, 7
- Avoid use during intercurrent illness in patients with chronic kidney disease to prevent further kidney damage 7